ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
XTR美国
1,587.000
-23.000
-1.43%
手动刷新
成交量:
570.00
成交额:
90.34万
市值:
387.05亿
市盈率:
- -
高:
1,587.000
开:
1,586.500
低:
1,581.000
收:
1,610.000
52周最高:
1,648.000
52周最低:
1,117.500
股本:
2,438.87万
香港流通股本:
2,438.87万
量比:
6.13
换手率:
0.00%
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
市销率:
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
绿叶制药(02186):新药LY03020在美国获准开展临床试验
智通财经
·
2025/01/14
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/03020"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03020","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03020\",,,,,undefined,":{"symbol":"03020","market":"HK","secType":"STK","nameCN":"XTR美国","latestPrice":1587,"timestamp":1770364368140,"preClose":1610,"halted":0,"volume":570,"delay":0,"changeRate":-0.014285714285714285,"floatShares":24388666,"shares":24388666,"eps":0,"marketStatus":"休市中","change":-23,"latestTime":"02-06 15:52:48","open":1586.5,"high":1587,"low":1581,"amount":903427,"amplitude":0.003727,"askPrice":0,"askSize":0,"bidPrice":1582,"bidSize":60,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1246982400000,"exchange":"SEHK","adjPreClose":1610,"nav":1582.924898,"aum":63669545798.345,"bidAskSpread":0,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":6.129036212281426,"lotSize":15,"spreadScale":3,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03020\",,,,,undefined,":{"symbol":"03020","floatShares":24388666,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.129036212281426,"shares":24388666,"dividePrice":0,"high":1587,"amplitude":0.003727,"preClose":1610,"low":1581,"week52Low":1117.5,"pbRate":"--","week52High":1648,"institutionHeld":0,"latestPrice":1587,"committee":1,"eps":0,"divideRate":0,"volume":570,"delay":0,"ttmEps":0,"open":1586.5,"prevYearClose":1602,"prevWeekClose":1610.5,"prevMonthClose":1610.5,"prevQuarterClose":1602,"fiveDayClose":1610.5,"twentyDayClose":1615,"sixtyDayClose":1577},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03020\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03020\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03020\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03020\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503520819","title":"绿叶制药(02186):新药LY03020在美国获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2503520819","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503520819?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 21:05","pubTimestamp":1736859957,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主开发的新一代抗精神病药物LY03020已获得美国食品药品监督管理局许可开展临床试验,拟用于治疗精神分裂症。LY03020基于集团新分子实体╱新治疗实体技术平台开发,是全球首个痕量胺相关受体1和5-羟色胺2C受体双靶点激动剂。LY03020亦在中国进入临床阶段。临床前研究已表明,LY03020可显著改善精神分裂症阳性、阴性症状和认知障碍,且未见明显的EPS和体重增加、糖脂代谢异常等代谢综合征风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1576","BK1583","03347","BK1606","02186","03020","BK1141"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/03020\",params:#limit:6,delay:false,,,undefined,":[]}}